Suppr超能文献

在使用 Ayahuasca 的仪式使用者中,人格、精神病理学、生活态度和神经认知表现:一项纵向研究。

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.

机构信息

Human Experimental Neuropsychopharmacology, IIB Sant Pau, Barcelona, Spain.

出版信息

PLoS One. 2012;7(8):e42421. doi: 10.1371/journal.pone.0042421. Epub 2012 Aug 8.

Abstract

Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT(2A) agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North America. Members of these groups typically ingest ayahuasca at least twice per month. Prior research has shown that acute ayahuasca increases blood flow in prefrontal and temporal brain regions and that it elicits intense modifications in thought processes, perception and emotion. However, regular ayahuasca use does not seem to induce the pattern of addiction-related problems that characterize drugs of abuse. To study the impact of repeated ayahuasca use on general psychological well-being, mental health and cognition, here we assessed personality, psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users (n = 127) and controls (n = 115) at baseline and 1 year later. Controls were actively participating in non-ayahuasca religions. Users showed higher Reward Dependence and Self-Transcendence and lower Harm Avoidance and Self-Directedness. They scored significantly lower on all psychopathology measures, showed better performance on the Stroop test, the Wisconsin Card Sorting Test and the Letter-Number Sequencing task from the WAIS-III, and better scores on the Frontal Systems Behavior Scale. Analysis of life attitudes showed higher scores on the Spiritual Orientation Inventory, the Purpose in Life Test and the Psychosocial Well-Being test. Despite the lower number of participants available at follow-up, overall differences with controls were maintained one year later. In conclusion, we found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment in the ayahuasca-using group.

摘要

安非他命是一种亚马逊精神活性植物饮料,含有血清素能 5-HT(2A) 激动剂 N,N-二甲基色胺 (DMT) 和单胺氧化酶抑制生物碱(哈梅林、哈马灵和四氢哈马灵),使其具有口服活性。安非他命的摄入是几个巴西融合教堂的核心特征,这些教堂已经将其活动扩展到巴西城市、欧洲和北美。这些团体的成员通常每月至少摄入两次安非他命。先前的研究表明,急性安非他命会增加前额叶和颞叶脑区的血流量,并且会引起思维过程、感知和情绪的强烈改变。然而,定期使用安非他命似乎不会引起滥用药物所特有的与成瘾相关的问题模式。为了研究重复使用安非他命对一般心理健康、精神健康和认知的影响,我们在这里评估了定期安非他命使用者(n = 127)和对照组(n = 115)的人格、精神病理学、生活态度和神经认知表现,基线和 1 年后。对照组积极参与非安非他命宗教。使用者表现出更高的奖励依赖和自我超越,更低的回避和自我导向。他们在所有精神病理学测量中得分明显较低,在 Stroop 测试、威斯康星卡片分类测试和 WAIS-III 的字母数字序列任务中表现更好,在额叶系统行为量表上得分更高。生活态度分析显示,精神取向量表、生活目的测试和心理社会健康测试的得分更高。尽管在随访时可用的参与者人数较少,但一年后与对照组的总体差异仍得以维持。总之,我们没有发现使用安非他命的群体存在心理失调、精神健康恶化或认知障碍的证据。

相似文献

2
Assessment of addiction severity among ritual users of ayahuasca.
Drug Alcohol Depend. 2010 Oct 1;111(3):257-61. doi: 10.1016/j.drugalcdep.2010.03.024. Epub 2010 Jun 15.
3
Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca.
J Psychoactive Drugs. 2020 Jul-Aug;52(3):264-272. doi: 10.1080/02791072.2020.1752960. Epub 2020 May 2.
4
Chemical Composition of Traditional and Analog Ayahuasca.
J Psychoactive Drugs. 2021 Jan-Mar;53(1):65-75. doi: 10.1080/02791072.2020.1815911. Epub 2020 Sep 8.
5
Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users.
J Psychoactive Drugs. 2019 Jan-Mar;51(1):3-11. doi: 10.1080/02791072.2018.1557355. Epub 2018 Dec 22.
8
Modulatory effects of ayahuasca on personality structure in a traditional framework.
Psychopharmacology (Berl). 2020 Oct;237(10):3161-3171. doi: 10.1007/s00213-020-05601-0. Epub 2020 Jul 23.
9
Psychological and neuropsychological assessment of regular hoasca users.
Compr Psychiatry. 2016 Nov;71:95-105. doi: 10.1016/j.comppsych.2016.09.003. Epub 2016 Sep 12.
10
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
Eur Neuropsychopharmacol. 2015 Apr;25(4):483-92. doi: 10.1016/j.euroneuro.2015.01.008. Epub 2015 Jan 16.

引用本文的文献

2
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):1-9. doi: 10.1089/psymed.2023.0036. eCollection 2024 Mar.
3
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.
J Psychoactive Drugs. 2025 Feb 20:1-11. doi: 10.1080/02791072.2025.2465800.
7
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.
PCN Rep. 2023 Oct 2;2(4):e146. doi: 10.1002/pcn5.146. eCollection 2023 Dec.
10
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.
Neuroethics. 2024;17(1):3. doi: 10.1007/s12152-023-09536-z. Epub 2023 Nov 6.

本文引用的文献

1
Enhancing neuropsychological performance in chronic cannabis users: the role of motivation.
J Clin Exp Neuropsychol. 2012;34(4):405-15. doi: 10.1080/13803395.2011.646957. Epub 2012 Jan 25.
2
Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects.
Psychiatry Res. 2011 Dec 30;194(3):287-295. doi: 10.1016/j.pscychresns.2011.04.010. Epub 2011 Nov 1.
3
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
J Clin Psychopharmacol. 2011 Dec;31(6):717-26. doi: 10.1097/JCP.0b013e31823607f6.
4
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
J Psychopharmacol. 2011 Nov;25(11):1453-61. doi: 10.1177/0269881111420188. Epub 2011 Sep 28.
5
Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.
Hum Brain Mapp. 2012 Nov;33(11):2550-60. doi: 10.1002/hbm.21381. Epub 2011 Sep 16.
6
Neuropsychological profiling of impulsivity and compulsivity in cocaine dependent individuals.
Psychopharmacology (Berl). 2012 Jan;219(2):673-83. doi: 10.1007/s00213-011-2485-z. Epub 2011 Sep 16.
7
Pharmacology of ayahuasca administered in two repeated doses.
Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. doi: 10.1007/s00213-011-2434-x. Epub 2011 Aug 13.
10
Study of metamemory in patients with chronic alcoholism using a feeling-of-knowing episodic memory task.
Alcohol Clin Exp Res. 2010 Nov;34(11):1888-98. doi: 10.1111/j.1530-0277.2010.01277.x. Epub 2010 Aug 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验